Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

MLA

Bagatell R, et al. “Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report from the International Neuroblastoma Risk Group Database.” Journal of Clinical Oncology, vol. 27, no. 3, Jan. 2009, pp. 365–70. EBSCOhost, https://doi.org/10.1200/JCO.2008.17.9184.

APA

Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL, Bagatell, R., Beck-Popovic, M., London, W. B., Zhang, Y., Pearson, A. D. J., Matthay, K. K., Monclair, T., Ambros, P. F., Cohn, S. L., & International Neuroblastoma Risk Group. (2009). Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database. Journal of Clinical Oncology, 27(3), 365–370. https://doi.org/10.1200/JCO.2008.17.9184

Chicago

Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, et al. 2009. “Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report from the International Neuroblastoma Risk Group Database.” Journal of Clinical Oncology 27 (3): 365–70. doi:10.1200/JCO.2008.17.9184.